RHYTHM PHARMACEUTICALS, INC.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | — |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| Gross Margin | — | — | — | — |
| Operating Expenses | ||||
| Research & Development | $50.3M | $22.9M | $19.6M | $7.1M |
| SG&A Expense | $28.1M | $9.5M | $6.3M | $3.4M |
| Operating Income | $-78.4M | $-32.4M | $-25.9M | $-10.6M |
| Operating Margin | — | — | — | — |
| Interest Expense | — | — | — | — |
| Pretax Income | — | — | — | — |
| Income Tax Expense | — | — | — | — |
| Net Income | $-74.1M | $-33.7M | $-25.9M | $-11.1M |
| Net Margin | — | — | — | — |
| EPS (Basic) | $-2.39 | $-2.83 | $-2.85 | $-1.18 |
| EPS (Diluted) | $-2.39 | $-2.83 | $-2.85 | $-1.18 |
| Shares Outstanding (Basic) | 34.4M | 27.3M | 10.2M | — |
| Shares Outstanding (Diluted) | 34.4M | 27.3M | 10.2M | — |
| Dividends Per Share | — | — | — | — |